A risk related value of spend for saving a statistical life

Jackson, David A.; Stone, Denise M.; Butler, Gregg; McGlynn, Grace

doi:10.1051/radiopro:2005s1-143

Cited by 3 publications

(2 citation statements)

References 4 publications

(1 reference statement)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The average in the UK fluctuated around $US4 million, with a broad range between $US2 and $US10 million (Jackson et al, 2005).…”

Section: How Expensive Is One Avoided Msv Of Low-level Population Expmentioning

confidence: 99%

Regulatory low dose limits: from science to political correctness?

Becker¹

2006

IJLR

View full text Add to dashboard Cite

The setting of regulatory low dose limits has become a topic of central importance for further radiation uses because of its close relationship to:• the public acceptance of nuclear power as a safe, inexpensive, reliable, ecologically beneficial, and climatically neutral source of electricity • the use of various highly beneficial medical, industrial and research applications • the exploding costs for remediation and decommissioning of sites and facilities, waste management, storage and transport of radioactive materials, etc.Unfortunately, the initially quite reasonable ICRP Recommendations have degenerated over the decades into the applications of the LNT/Collective Dose dogma. With the accumulation of new radiobiological and epidemiological results during the last two decades, the scientific basis of LNT became increasingly questionable. At the same time, non-scientific political and ideological pressures on the limit-setting international and national authorities increased. In this paper, some trends leading to the low-dose recommendations in the ICRP 2005 draft, as well as likely problems in their implementation, are briefly discussed.

show abstract

“…The average in the UK fluctuated around $US4 million, with a broad range between $US2 and $US10 million (Jackson et al, 2005).…”

Section: How Expensive Is One Avoided Msv Of Low-level Population Expmentioning

confidence: 99%

Regulatory low dose limits: from science to political correctness?

Becker¹

2006

IJLR

View full text Add to dashboard Cite

show abstract

“…A series of values for the value of a life year (VOLY) lost are put forth in the literature, ranging from €21,000 to €56,000 for all age groups. In Canada, Krupnick et al, (176) found a value of a statistical life to be C$0.6 million for people aged 70 and above (€460,000 unadjusted) and in the UK, Jackson et al, (177) found the value of life to be £300,000 (€450,000 unadjusted). The latter estimates are valued using a technique based on willingnessto-pay (for reduction in current and future risk of death) rather than on market earnings.…”

Section: Costmentioning

confidence: 99%

Study of patients with iron deficiency and HF in Ireland: prevalence and treatment budget impact

Wong

Redmond²,

Blaine

et al. 2021

Br J Cardiol

View full text Add to dashboard Cite

Findings of the report demonstrate "a profound regional disparity in Heart Failure patient data, services and outcomes nationwide" a €660m a Medication Drug costs account for Primary care 25% 16% suffer from symptoms such as severe breathlessness and fatigue b Patients are less able to work/participate in social activities, and are likely to suffer from depression and social isolation c Quality of Life "...it felt like I was drowning" 80% related costs* account for of total direct cost** of Heart Failure a of total direct cost of Heart Failure a Patients report greater physical impairment than patients with arthritis and chronic lung disease m 90,000 Lack of awareness of signs and symptoms 10,000+

show abstract